Thrombophilia, antikoaguláns terápia és terhesség.

Translated title of the contribution: Thrombophilia, anticoagulant therapy and pregnancy

Z. Boda, P. László, G. Pfliegler, I. Tornai, L. Rejtö, A. Schlammadinger

Research output: Contribution to journalArticle

6 Citations (Scopus)


Thromboembolic complications during pregnancy are the most common causes of maternal death. Here we report on thromboembolic prophylaxis of 60 pregnancies of 32 pregnant women with familial thrombophilia. Long-term Fraxiparine (Sanofi-Chinoin) as thromboprophylaxis was applied in 26 cases throughout pregnancy. UFH (Heparin-Ca inj.) was used in 11 cases, and there were 23 pregnancies without thromboembolic prophylaxis in our patient's case histories. Artificial abortions were not included in this paper. The ratio of successful pregnancies were: with Fraxiparine: 24/26 (92.3%), with UFH (Heparin-Ca): 8/11 (72.7%), without prophylaxis: 4/23 (17.4%). In the patient group treated with Fraxiparine there were no foetopathy, thrombocytopenia or bleeding complication. LMWH is recommended for pregnant women with familial thrombophilia. According to literature data and our own experiences the doses of LMWH in patients with familial thrombophilia, and -antiphospholipid syndrome, and -artificial heart value are suggested.

Translated title of the contributionThrombophilia, anticoagulant therapy and pregnancy
Original languageHungarian
Pages (from-to)3113-3116
Number of pages4
JournalOrvosi hetilap
Issue number52
Publication statusPublished - Dec 27 1998

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Thrombophilia, anticoagulant therapy and pregnancy'. Together they form a unique fingerprint.

  • Cite this

    Boda, Z., László, P., Pfliegler, G., Tornai, I., Rejtö, L., & Schlammadinger, A. (1998). Thrombophilia, antikoaguláns terápia és terhesség. Orvosi hetilap, 139(52), 3113-3116.